These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7958718)

  • 1. Pharmacological properties of KRN2391, a novel vasodilator of the nitrate-potassium channel opener hybrid type.
    Ogawa N
    Gen Pharmacol; 1994 Jul; 25(4):609-16. PubMed ID: 7958718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the nitrate-like and K channel opening actions of KRN2391 in canine coronary arterial smooth muscle.
    Okada Y; Yanagisawa T; Taira N
    Br J Pharmacol; 1991 Dec; 104(4):829-38. PubMed ID: 1810597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K+ channel-opening action and KRN2391-induced reduction of Ca2+ sensitivity of arterial smooth muscle.
    Okada Y; Yanagisawa T; Yamagishi T; Taira N
    Arch Int Pharmacodyn Ther; 1993; 326():33-51. PubMed ID: 8185411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the nitrate-like and potassium channel opening actions of KRN2391 in canine coronary arterial smooth muscle.
    Okada Y; Yamagishi T; Yanagisawa T; Taira N
    Jpn J Pharmacol; 1992; 58 Suppl 2():333P. PubMed ID: 1507582
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo K channel-opening effects of Ki3315, a metabolite of the novel vasodilator KRN2391.
    Tanaka Y; Okada Y; Yokoyama T; Nakajima T; Izawa T; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 326():62-71. PubMed ID: 8185414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator effects of KRN2391, levcromakalim and 3-morpholino-sydnonimin in human pial and omental arteries.
    Petersson J; Ryman T; Högestätt ED
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):68-73. PubMed ID: 10935535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of hypotension induced by KRN2391 and nicardipine in isoflurane anaesthetized dogs.
    Takeda S; Ozawa Y; Tomaru T
    Can J Anaesth; 1997 Sep; 44(9):1002-7. PubMed ID: 9305565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery.
    Okada Y; Yokoyama T; Jinno Y; Kashiwabara T; Izawa T; Fukushima H; Ogawa N
    Eur J Pharmacol; 1993 Sep; 241(2-3):177-81. PubMed ID: 8243553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig.
    Harada K; Miwa A; Yokoyama T; Izawa T; Ogawa N; Jinno Y
    Gen Pharmacol; 1994 Sep; 25(5):935-9. PubMed ID: 7835640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological analysis of the vasodepressor effect of KRN2391 in pithed rats.
    Tanaka Y; Yokoyama T; Kashiwabara T; Fukushima H; Izawa T; Ogawa N
    Gen Pharmacol; 1993 Nov; 24(6):1379-81. PubMed ID: 8112509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs.
    Ogawa N; Kaneta S; Jinno Y; Kasai H; Nishikori K; Fukushima H
    Arch Int Pharmacodyn Ther; 1992; 318():36-46. PubMed ID: 1463370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of KRN2391 and other coronary dilators on porcine isolated coronary arteries of different sizes.
    Kasai H; Jinno Y; Kaneta S; Fukata Y; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Jun; 45(6):573-5. PubMed ID: 8103109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart.
    Miwa A; Jinno Y; Yokoyama T; Izawa T; Ogawa N
    Gen Pharmacol; 1994 May; 25(3):471-4. PubMed ID: 7926593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of KRN2391 on ionic currents in rabbit femoral arterial myocytes.
    Muraki K; Sasaoka A; Watanabe M; Imaizumi Y
    Br J Pharmacol; 2001 Mar; 132(5):1154-60. PubMed ID: 11226147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery.
    Yokoyama T; Okada Y; Jinno Y; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Sep; 25(5):941-5. PubMed ID: 7835641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and vasorelaxant effects on KRN2391 in spontaneously hypertensive rats.
    Kashiwabara T; Okada Y; Ogawa N; Fukushima H
    Gen Pharmacol; 1994 May; 25(3):487-94. PubMed ID: 7926595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.